Advertisement

Topics

With Goals to Combat Antibiotic Resistance, Qpex Biopharma Launches with $33M

20:00 EDT 21 Oct 2018 | BioSpace

Qpex Biopharma, a company spun-out of The Medicines Company focused on the development of anti-infective assets, launched this morning supported by a $33 million Series A financing round and a BARDA contract worth up to $132 million.

Original Article: With Goals to Combat Antibiotic Resistance, Qpex Biopharma Launches with $33M

NEXT ARTICLE

More From BioPortfolio on "With Goals to Combat Antibiotic Resistance, Qpex Biopharma Launches with $33M"

Advertisement
Quick Search
Advertisement
Advertisement